Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy G Cooke

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Immunological Methods|February 28, 2007
Quantifying tumour-infiltrating lymphocyte subsets: a practical immuno-histochemical methodPaula M Loughlin, Timothy G Cooke, W David George, et al.
Breast Cancer Research : BCR|April 16, 2004
Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labellingSian M Tovey, Caroline J Witton, John M S Bartlett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patientsLiane M McGlynn, Tove Kirkegaard, Joanne Edwards, et al.
Histopathology|January 28, 2010
Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISHTove Kirkegaard, Caroline J Witton, Joanne Edwards, et al.
American Journal of Clinical Pathology|April 23, 2008
Expression of tumor necrosis factor alpha converting enzyme in endocrine cancersTove Kirkegaard, Anjali Naresh, Vicky S Sabine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patientsTove Kirkegaard, Liane M McGlynn, Fiona M Campbell, et al.
The American Journal of Pathology|September 19, 2009
Is expression or activation of Src kinase associated with cancer-specific survival in ER-, PR- and HER2-negative breast cancer patients?Beatrix Elsberger, Bingchao A Tan, Thomas J Mitchell, et al.
Cancer Research|June 17, 2006
The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cellsAnjali Naresh, Weiwen Long, Gregory A Vidal, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Immunological Methods|February 28, 2007
Quantifying tumour-infiltrating lymphocyte subsets: a practical immuno-histochemical methodPaula M Loughlin, Timothy G Cooke, W David George, et al.
Breast Cancer Research : BCR|April 16, 2004
Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labellingSian M Tovey, Caroline J Witton, John M S Bartlett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patientsLiane M McGlynn, Tove Kirkegaard, Joanne Edwards, et al.
Histopathology|January 28, 2010
Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISHTove Kirkegaard, Caroline J Witton, Joanne Edwards, et al.
American Journal of Clinical Pathology|April 23, 2008
Expression of tumor necrosis factor alpha converting enzyme in endocrine cancersTove Kirkegaard, Anjali Naresh, Vicky S Sabine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patientsTove Kirkegaard, Liane M McGlynn, Fiona M Campbell, et al.
The American Journal of Pathology|September 19, 2009
Is expression or activation of Src kinase associated with cancer-specific survival in ER-, PR- and HER2-negative breast cancer patients?Beatrix Elsberger, Bingchao A Tan, Thomas J Mitchell, et al.
Cancer Research|June 17, 2006
The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cellsAnjali Naresh, Weiwen Long, Gregory A Vidal, et al.
Pageof 2